Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
The Use of D-Cycloserine to Augment CBT for Pediatric OCD
for
Obsessive-Compulsive Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 7 - 17
Code: NCT01687140
Phase2, Recruiting
Diet in the Management of Acromegaly
for
Acromegaly
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05401084
Recruiting
Stem Cells Found in the Abdominal Cavity in Humans
for
Intra-abdominal Surgery
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 60
Code: NCT00576264
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Los Angeles CA, Phoenix AZ, Sacramento CA, Murray UT,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
Cord Clamping Among Neonates With Congenital Heart Disease
for
Congenital Heart Disease (CHD)
Location: Los Angeles CA, San Diego CA, Salt Lake City UT,
Sponsor: Carl Backes, MD
Sex: All
Age: 0
Code: NCT06153459
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Non Exudative AMD Imaged With SS-OCT- Extension
for
Dry Macular Degeneration
Location: Los Angeles CA, Miami FL, New York NY, Boston MA
Sponsor: Boston Image Reading Center
Sex: All
Age: 0+
Code: NCT04469140
Recruiting
Lurbinectedin in FET-Fused Tumors
for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Los Angeles CA, Iowa City IA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 10+
Code: NCT05918640
Phase1, Phase2, Recruiting
SynCardia 70cc TAH-t for Destination Therapy (DT)
for
Life-threatening, Biventricular Heart Failure,
Location: Los Angeles CA, Phoenix AZ, Tucson AZ, Oklahoma City OK,
Sponsor: SynCardia Systems. LLC
Sex: All
Age: 19+
Code: NCT02232659
Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Location: Los Angeles CA, Calgary, Houston TX, Iowa City IA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 12+
Code: NCT04924075
Phase2, Recruiting
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
for
Colonic Neoplasms
Location: Los Angeles CA, Portland OR, Seattle WA, Houston TX,
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT00843375
Recruiting
Whole Brain Vessel Wall Imaging in Stroke Patients (WISP): An International Multi-Center Registry
for
Ischemic Stroke
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT02923752
Recruiting
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
for
Crohn Disease
Location: Los Angeles CA, Phoenix AZ, San Francisco CA,
Sponsor: Connecticut Children's Medical Center
Sex: All
Age: 6 - 17
Code: NCT05781152
Recruiting
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
for
Glioblastoma Multiforme
Location: Los Angeles CA, Santa Monica CA, San Francisco CA,
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05708352
Phase2, Recruiting
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
for
NAD+ Levels in the Blood
Location: Carlsbad CA
Sponsor: Qualia Life Sciences
Sex: All
Age: 40 - 65
Code: NCT06505967
Recruiting
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
for
Prostate Cancer
Location: Los Angeles CA
Sponsor: Stephen Freedland
Sex: Male
Age: 18+
Code: NCT03824652
Phase2, Recruiting
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS